コミナティ筋注5～11歳用の用法・用量追加承認について｜厚生労働省
https://www.mhlw.go.jp/stf/newpage_27677.htmlBundle the HTML, screenshot, summaries, and metadata into one ZIP file. Pro saves automatically start preparing the external RFC 3161 timestamp, and only unfinished records need one more preparation step before download.
コミナティ筋注5～11歳用の用法・用量追加承認について｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces the Ministry of Health, Labour and Welfare's approval on August 30, 2022, of additional dosage and administration instructions for Comirnaty injection for ages 5-11. Developed by Pfizer, this COVID-19 vaccine prevents SARS-CoV-2 infection. The approved dosing includes initial immunization with two 0.2mL doses administered intramuscularly at three-week intervals, followed by a single 0.2mL booster dose. The vaccine is diluted in saline solution prior to administration.
